Promega Opens New Shanghai Facility

Promega Opens New Shanghai Facility

MADISON, Wis.-- Nov. 14, 2012 --Promega Corporation celebrates the opening of a new facility for its China operations. The new site for Shanghai Promega Biological Products, Ltd. both replaces an existing molecular biology reagent production site and it provides additional research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market.

"China is an integral part of Promega's manufacturing and business operations. In 1985, Promega and two Chinese partners established Sino-American Biotechnology Corporation (SABC), the first China-US biotech joint venture in China"

Since its purchase in June of this year, the building has been equipped for the manufacture of molecular biology and molecular diagnostic reagents. Under the leadership of General Manager Tom Duan, a team of 40 scientists, technicians and administrators will begin operations in the new facility in the next few weeks.

"China is an integral part of Promega's manufacturing and business operations. In 1985, Promega and two Chinese partners established Sino-American Biotechnology Corporation (SABC), the first China-US biotech joint venture in China," says Promega CEO Bill Linton. "This recent investment in the new Shanghai cGMP manufacturing facility represents Promega's continued commitment to life science in China." Among its 15 global branches, Promega also has a sales and marketing branch in Beijing.

The new facility, called Shanghai Promega Life Science Center, is one of five Promega manufacturing sites worldwide. Together these facilities manufacture biological and chemical reagents and instruments used in both life science research and molecular diagnostics. Promega products are manufactured under certified quality systems that meet the requirement of ISO 9001 or ISO 13485, depending on product intended use.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Suggested Articles

Pfizer says two lots of migraine med Relpax failed to meet microbial standards and may be contaminated with genera pseudomonas and burkholderia.

Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.

The FDA has slapped a warning letter on an Indian solvent recycler that may have contributed to the contamination of blood pressure meds.